RPS12P24

Across TCGA pan-cancer cohorts, RPS12P24 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPS12P24’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPS12P24 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS12P24 is over-expressed in tumor, although a few such as STAD and KIRC show the opposite, repressed pattern.

STAD, COAD, and HNSC are the cancer types where RPS12P24 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS12P24 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	−0.066	.034	2	view →
COAD	All	II,III,IV	+0.059	.015	2	view →
HNSC	All	IV	+0.067	.018	1	view →
KIRC	Male	II,III,IV	−0.018	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPS12P24–STAD

Open the STAD breakdown →